Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Bodmer Mark Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 4 Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Sold 3,128 shares @ $9.51, valued at $29.7k
Exercised 6,625 restricted stock units @ $0
06/12/2023 4 Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Sold 22,571 shares @ $0.1418, valued at $3.2k
05/10/2023 4 Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Sold 68,014 shares @ $0.1255, valued at $8.5k
05/09/2023 4 Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Exercised 132,500 restricted stock units @ $0
02/09/2023 4 Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 530,000 restricted stock units @ $0
01/21/2022 4 Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 125,000 options to buy @ $5.05, valued at $631.3k
01/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2020 4 Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 100,000 options to buy @ $7.06, valued at $706k
01/16/2019 4 Bodmer Mark (CSO, President of R&D) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 100,000 options to buy @ $13.71, valued at $1.4M
05/10/2018 4 Bodmer Mark (See Remarks) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 55,437 options @ $16, valued at $887k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy